FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068532562> ?p ?o ?g. }

• W2068532562 endingPage "70" @default.
• W2068532562 startingPage "62" @default.
• W2068532562 abstract "Therapy with the oral antidiabetic agent troglitazone (Rezulin) has been associated with cases of severe hepatotoxicity and drug-induced liver failure, which led to the recent withdrawal of the product from the U.S. market. While the mechanism of this toxicity remains unknown, it is possible that chemically reactive metabolites of the drug play a causative role. In an effort to address this possibility, this study was undertaken to determine whether troglitazone undergoes metabolism in human liver microsomal preparations to electrophilic intermediates. Following incubation of troglitazone with human liver microsomes and with cDNA-expressed cytochrome P450 isoforms in the presence of glutathione (GSH), a total of five GSH conjugates (M1-M5) were detected and identified tentatively by LC-MS/MS analysis. In two cases (M1 and M5), the structures of the adducts were confirmed by NMR spectroscopy and/or by comparison with an authentic standard prepared by synthesis. The formation of GSH conjugates M1-M5 revealed the operation of two distinct metabolic activation pathways for troglitazone, one of which involves oxidation of the substituted chromane ring system to a reactive o-quinone methide derivative, while the second involves a novel oxidative cleavage of the thiazolidinedione (TZD) ring, potentially generating highly electrophilic alpha-ketoisocyanate and sulfenic acid intermediates. When troglitazone was administered orally to a rat, samples of bile were found to contain GSH conjugates which reflected the operation of these same metabolic pathways in vivo. The finding that metabolism of the TZD ring of troglitazone was catalyzed selectively by P450 3A enzymes is significant in light of the recent report that troglitazone is an inducer of this isoform in human hepatocytes. The implications of these results are discussed in the context of the potential for troglitazone to covalently modify hepatic proteins and to cause oxidative stress through redox cycling processes, either of which may play a role in drug-induced liver injury." @default.
• W2068532562 created "2016-06-24" @default.
• W2068532562 creator A5003058999 @default.
• W2068532562 creator A5009624283 @default.
• W2068532562 creator A5022210942 @default.
• W2068532562 creator A5033124982 @default.
• W2068532562 creator A5038118766 @default.
• W2068532562 creator A5059073096 @default.
• W2068532562 creator A5064742965 @default.
• W2068532562 creator A5080625098 @default.
• W2068532562 creator A5080688603 @default.
• W2068532562 creator A5084683523 @default.
• W2068532562 date "2000-12-08" @default.
• W2068532562 modified "2023-10-10" @default.
• W2068532562 title "Studies on the Metabolism of Troglitazone to Reactive Intermediates in Vitro and in Vivo. Evidence for Novel Biotransformation Pathways Involving Quinone Methide Formation and Thiazolidinedione Ring Scission" @default.
• W2068532562 cites W1995481117 @default.
• W2068532562 cites W2001881588 @default.
• W2068532562 cites W2002583489 @default.
• W2068532562 cites W2003856834 @default.
• W2068532562 cites W2013326347 @default.
• W2068532562 cites W2017467910 @default.
• W2068532562 cites W2061835032 @default.
• W2068532562 cites W2073903529 @default.
• W2068532562 doi "https://doi.org/10.1021/tx000180q" @default.
• W2068532562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11170509" @default.
• W2068532562 hasPublicationYear "2000" @default.
• W2068532562 type Work @default.
• W2068532562 sameAs 2068532562 @default.
• W2068532562 citedByCount "279" @default.
• W2068532562 countsByYear W20685325622012 @default.
• W2068532562 countsByYear W20685325622013 @default.
• W2068532562 countsByYear W20685325622014 @default.
• W2068532562 countsByYear W20685325622015 @default.
• W2068532562 countsByYear W20685325622016 @default.
• W2068532562 countsByYear W20685325622017 @default.
• W2068532562 countsByYear W20685325622018 @default.
• W2068532562 countsByYear W20685325622019 @default.
• W2068532562 countsByYear W20685325622020 @default.
• W2068532562 countsByYear W20685325622021 @default.
• W2068532562 countsByYear W20685325622022 @default.
• W2068532562 countsByYear W20685325622023 @default.
• W2068532562 crossrefType "journal-article" @default.
• W2068532562 hasAuthorship W2068532562A5003058999 @default.
• W2068532562 hasAuthorship W2068532562A5009624283 @default.
• W2068532562 hasAuthorship W2068532562A5022210942 @default.
• W2068532562 hasAuthorship W2068532562A5033124982 @default.
• W2068532562 hasAuthorship W2068532562A5038118766 @default.
• W2068532562 hasAuthorship W2068532562A5059073096 @default.
• W2068532562 hasAuthorship W2068532562A5064742965 @default.
• W2068532562 hasAuthorship W2068532562A5080625098 @default.
• W2068532562 hasAuthorship W2068532562A5080688603 @default.
• W2068532562 hasAuthorship W2068532562A5084683523 @default.
• W2068532562 hasConcept C134018914 @default.
• W2068532562 hasConcept C161790260 @default.
• W2068532562 hasConcept C170493617 @default.
• W2068532562 hasConcept C181199279 @default.
• W2068532562 hasConcept C185592680 @default.
• W2068532562 hasConcept C187345961 @default.
• W2068532562 hasConcept C192937433 @default.
• W2068532562 hasConcept C192989942 @default.
• W2068532562 hasConcept C202751555 @default.
• W2068532562 hasConcept C2776923340 @default.
• W2068532562 hasConcept C2777180221 @default.
• W2068532562 hasConcept C2778150266 @default.
• W2068532562 hasConcept C526171541 @default.
• W2068532562 hasConcept C538909803 @default.
• W2068532562 hasConcept C55493867 @default.
• W2068532562 hasConcept C555293320 @default.
• W2068532562 hasConcept C62231903 @default.
• W2068532562 hasConcept C86803240 @default.
• W2068532562 hasConcept C87644729 @default.
• W2068532562 hasConcept C89311334 @default.
• W2068532562 hasConcept C98274493 @default.
• W2068532562 hasConceptScore W2068532562C134018914 @default.
• W2068532562 hasConceptScore W2068532562C161790260 @default.
• W2068532562 hasConceptScore W2068532562C170493617 @default.
• W2068532562 hasConceptScore W2068532562C181199279 @default.
• W2068532562 hasConceptScore W2068532562C185592680 @default.
• W2068532562 hasConceptScore W2068532562C187345961 @default.
• W2068532562 hasConceptScore W2068532562C192937433 @default.
• W2068532562 hasConceptScore W2068532562C192989942 @default.
• W2068532562 hasConceptScore W2068532562C202751555 @default.
• W2068532562 hasConceptScore W2068532562C2776923340 @default.
• W2068532562 hasConceptScore W2068532562C2777180221 @default.
• W2068532562 hasConceptScore W2068532562C2778150266 @default.
• W2068532562 hasConceptScore W2068532562C526171541 @default.
• W2068532562 hasConceptScore W2068532562C538909803 @default.
• W2068532562 hasConceptScore W2068532562C55493867 @default.
• W2068532562 hasConceptScore W2068532562C555293320 @default.
• W2068532562 hasConceptScore W2068532562C62231903 @default.
• W2068532562 hasConceptScore W2068532562C86803240 @default.
• W2068532562 hasConceptScore W2068532562C87644729 @default.
• W2068532562 hasConceptScore W2068532562C89311334 @default.
• W2068532562 hasConceptScore W2068532562C98274493 @default.
• W2068532562 hasIssue "1" @default.
• W2068532562 hasLocation W20685325621 @default.
• W2068532562 hasLocation W20685325622 @default.
• W2068532562 hasOpenAccess W2068532562 @default.

• next